Abstract:Poor aqueous solubility of crystalline active pharmaceutical ingredients (API) restricts their bioavailability. Amorphous solid dispersions with biocompatible polymer excipients offers a solution to overcome this problem, potentially enabling a broader use of many drug candidate molecules. This work addresses various aspects of in silico design of a suitable combination of an API and a polymer to form such a binary solid dispersion. Molecular interactions in such bulk systems are tracked at full atomic resolution within molecular-dynamics (MD) simulations, enabling to identify API – polymer pairs that exhibit the most beneficial interactions. Importance of those interactions is manifold: increasing the mutual miscibility, kinetic stabilization of their amorphous dispersions and impedance of the spurious recrystallization of the API component. MD tools are used to investigate the structural and cohesive properties of pure compounds and mixtures, with a special emphasis on molecular interactions, microscopic structure and internal dynamics. This analysis is then accompanied by a macroscopic image of the energetic compatibility and vitrification tendency of the mixtures in terms of their excess enthalpies and glass transition temperatures. Density-functional theory (DFT) and non-covalent interaction (NCI) analysis fortify our computational conclusions and enable us to map intensities of particular NCI among the individual target materials and relevant molecular sites therein. Three archetypal polymer excipients and four API molecules are included in this study. Results of our computational analysis of molecular interactions in bulk systems agree with the experimentally observed trends of solubility of the given API in polymers. Our calculations confirm PVP as the most potent acceptor of hydrogen bonding among the considered polymer excipients, whereas ibuprofen molecules are predicted to be the most efficient hydrogen bond donors among our target API. Our simulations also suggest that carbamazepine does not exhibit particularly strong interactions with the considered polymer excipients. Although current MD cannot offer quantitative accuracy of many of the discussed descriptors, current computational models focusing on NCI of API with polymer excipients contributes to understanding of the behavior of these materials at the molecular level, and thus also to the rational design of novel efficient drug formulations.

The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection

Co-crystal Phase Diagram Determination by the Solution Addition Method

Computational Support to Explore Ternary Solid Dispersions of Challenging Drugs Using Coformer and Hydroxypropyl Cellulose

Ternary phase diagram and investigation of slurry conversion of 1:1 sulfamethazine-acetylsalicylic acid cocrystal

Solvent dependent 4-aminosalicylic acid-sulfamethazine co-crystal polymorph control

Solid–Liquid Equilibrium in Co-Amorphous Systems: Experiment and Prediction

Solvent Effect on Molecular Conformational Evolution and Polymorphic Manipulation of Cimetidine

Polymorph selection of pharmaceutical cocrystals via bench-top and continuous production techniques

Crystallization solvent design based on a new quantitative prediction model of crystal morphology

Shortcut Method for Solubility Prediction and Preferred Stability of Diastereomeric Cocrystals

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Cocrystal Solubility Advantage and Dose/Solubility Ratio Diagrams: A Mechanistic Approach To Selecting Additives and Controlling Dissolution-Supersaturation-Precipitation Behavior

Molecular Insights on Kinetic Stabilization of Amorphous Solid Dispersion of Pharmaceuticals

Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.

Co-Crystallization: A Novel Technique to Improvise the Pharmaceutical Characteristics of API's

Energy partitioning of pharmaceutical cocrystal structures

Modeling and predicting the influence of variable factors on dissolution of crystalline pharmaceuticals

Dissolution Of Crystalline Pharmaceuticals: Experimental Investigation And Thermodynamic Modeling

Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs)

Identification and Pharmaceutical Characterization of a New Itraconazole Terephthalic Acid Cocrystal

Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design